Issues related to home health and hospice payment policies and funding (CY 2024 Home Health Proposed Rule), program integrity matters and quality metrics, continuation of hospital-at-home; Hospice Special Focus Program included in the CY 2024 Home Health Proposed and Final Rule; Issues related to healthcare workforce matters; Preserving Access to Home Health Act of 2023 (S. 2137/H.R 5159)
Duration: January 1, 2013
to
March 31, 2014
General Issues: Medicare/Medicaid , Health Issues , Budget/Appropriations
Spending: about $10,336,257 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), U.S. Senate, House of Representatives, White House Office, Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Small Business Adminstration (SBA), Medicare Payment Advisory Commission (MedPAC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Scott M. Levy U.S. Department of Education (Feb. 2005 - Aug. 2006) - Confidential Assistant, White House Initiative on Tribal Colleges and Universities; Advance Representative, Office of the Secretary
Amy Pellegrino Sen. Olympia Snowe (Senior Policy Advisor)
Rep. Rob Simmons (Legislative Assistant)
Sen. Olympia J. Snowe, Rep. Rob Simmons
Sen. Olympia Snowe, Rep. Rob Simmons
Sen. Olympia Snowwe, Rep. Rob Simmons
Dave Kemmerly n/a
Kathrine Jones n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Amedisys, Inc. had in-house lobbyists. The report was filed on April 22.
Original Filing: 301570313.xml
Lobbying Issues
Issues related to home health and hospice payment policies and funding (CY 2024 Home Health Proposed Rule), program integrity matters and quality metrics, continuation of hospital-at-home; Hospice Special Focus Program included in the CY 2024 Home Health Proposed and Final Rule; Issues related to healthcare workforce matters; Preserving Access to Home Health Act of 2023 (S. 2137/H.R 5159)
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2023
In Q4, Amedisys, Inc. had in-house lobbyists. The report was filed on Jan. 18.
Original Filing: 301527921.xml
Lobbying Issues
Issues related to home health and hospice payment policies and funding (CY 2024 Home Health Proposed Rule), program integrity matters and quality metrics, continuation of hospital-at-home; Hospice Special Focus Program included in the CY 2024 Home Health Proposed and Final Rule; Issues related to healthcare workforce matters; Preserving Access to Home Health Act of 2023 (S. 2137/H.R 5159)
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2023
In Q3, Amedisys, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2023.
Original Filing: 301508245.xml
Lobbying Issues
Issues related to home health and hospice payment policies (CY 2024 Home Health Proposed Rule), program integrity matters and quality metrics, continuation of hospital-at-home; Issues related to healthcare workforce matters; Preserving Access to Home Health Act of 2023 (S. 2137/H.R 5159)
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2023
In Q2, Amedisys, Inc. had in-house lobbyists. The report was filed on July 19, 2023.
Original Filing: 301483390.xml
Lobbying Issues
Issues related to home health and hospice payment policies, program integrity matters and quality metrics, continuation of hospital-at-home; Issues related to healthcare workforce matters; Preserving Access to Home Health Act of 2023 (S. 2137)
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2023
In Q1, Amedisys, Inc. had in-house lobbyists. The report was filed on April 20, 2023.
Original Filing: 301466052.xml
Lobbying Issues
Issues related to home health and hospice payment policies, program integrity matters and quality metrics; Issues related to healthcare workforce matters.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2022
In Q4, Amedisys, Inc. had in-house lobbyists. The report was filed on Jan. 18, 2023.
Original Filing: 301430536.xml
Lobbying Issues
Issues related to Centers for Medicare and Medicaid policies, including the CY 2023 Home Health Prospective Payment System Rate Update, FY 2023 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirement, H.R. 2471, Consolidated Appropriations Act of 2022, S. 3792/H.R. 7053, Hospital In-Patient Modernization Act of 2022, Monitoring progress of Build Back Better legislation, S. 4605/H.R. 8581, Preserving Access to Home Health Act of 2022; Issues related to hospice cap; 2023 Omnibus Appropriations bill
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2022
In Q3, Amedisys, Inc. had in-house lobbyists. The report was filed on Oct. 19, 2022.
Original Filing: 301411273.xml
Lobbying Issues
Issues related to Centers for Medicare and Medicaid policies, including the CY 2023 Home Health Prospective Payment System Rate Update, FY 2023 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirement, H.R. 2471, Consolidated Appropriations Act of 2022, S. 3792/H.R. 7053, Hospital In-Patient Modernization Act of 2022, Monitoring progress of Build Back Better legislation, S. 4605/H.R. 8581, Preserving Access to Home Health Act of 2022; Issues related to hospice cap
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2022
In Q2, Amedisys, Inc. had in-house lobbyists. The report was filed on July 15, 2022.
Original Filing: 301380852.xml
Lobbying Issues
Issues related to Centers for Medicare and Medicaid policies, including the CY 2023 Home Health Prospective Payment System Rate Update, FY 2023 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirement, HR 2471 the Consolidated Appropriations Act of 2022, S. 3792/HR 7053 the Hospital In-Patient Modernization Act of 2022, monitoring progress of Build Back Better legislation
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2022
In Q1, Amedisys, Inc. had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301364574.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy, including the Home Health Prospective Payment System Patient-Driven Groupings Model, Hospice payment and quality policy proposals, S. 2562 Choose Home Care Act of 2021, HR 2471 the Consolidated Appropriations Act of 2022, S.3792/H.R.7053 The Hospital Inpatient Services Modernization Act, operational issues related to the No-Pay RAP and Notice of Admission policies for home health, monitoring progress of Build Back Better legislation.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2021
In Q4, Amedisys, Inc. had in-house lobbyists. The report was filed on Jan. 14, 2022.
Original Filing: 301322543.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy, including CMMI Home Health Value Based Purchasing Demonstration; tracking American Rescue Plan and HR 1868 (To prevent across-the-board direct spending cuts, and for other purposes); CY 2022 Proposed Home Health Prospective Payment System Payment Update; Value Based Insurance Design Hospice Component; S. 2562, Choose Home Care Act of 2021; Federal Government Covid-19 vaccine mandates for healthcare workers; CMS Hospital at Home programs; Operational issues related to the CMS no-pay RAP policies for home health; monitoring Build Back Better legislation.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2021
In Q3, Amedisys, Inc. had in-house lobbyists. The report was filed on Oct. 15, 2021.
Original Filing: 301299926.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy, including CMMI Home Health Value Based Purchasing Demonstration; tracking American Rescue Plan and HR 1868 (To prevent across-the-board direct spending cuts, and for other purposes); CY 2022 Proposed Home Health Prospective Payment System Payment Update; Value Based Insurance Design Hospice Component; S. 2562, Choose Home Care Act of 2021; Federal Government Covid-19 vaccine mandates for healthcare workers; CMS Hospital at Home programs; Operational issues related to the CMS no-pay RAP policies for home health
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2021
In Q2, Amedisys, Inc. had in-house lobbyists. The report was filed on July 15, 2021.
Original Filing: 301277039.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy, including CMMI Home Health Value Based Purchasing Demonstration; tracking American Rescue Plan and HR 1868 (To prevent across-the-board direct spending cuts, and for other purposes); FY 2022 Proposed Hospice Wage Index and Payment Update; CY 2022 Proposed Home Health Prospective Payment System Payment Update; and Value Based Insurance Design Hospice Component.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2021
In Q1, Amedisys, Inc. had in-house lobbyists. The report was filed on April 16, 2021.
Original Filing: 301254879.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy, including CMMI Home Health Value Based Purchasing Demonstration; tracking American Rescue Plan and HR 1868 (To prevent across-the-board direct spending cuts, and for other purposes).
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2020
In Q4, Amedisys, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2021.
Original Filing: 301235216.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to COVID-19 and related legislation (H.R. 748 Coronavirus Aid, Relief, and Economic Security Act (CARES Act); H.R. 6201, Families First Coronavirus Response Act; H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act; H.R. 266 - Paycheck Protection Program and Health Care Enhancement Act; H.R. 133 - the Consolidated Appropriations Act, 2021) and related regulatory action including CMS-1744-IFC- Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency ; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2020
In Q3, Amedisys, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2020.
Original Filing: 301217828.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to COVID-19 and related legislation (H.R. 6201, Families First Coronavirus Response Act & H.R. 748 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)) and related regulatory action including CMS-1744-IFC- Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency ; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design; H.R. 6800 (Health and Economic Recovery Omnibus Emergency Solutions Act); H.R. 266 (Paycheck Protection Program and Health Care Enhancement Act).
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2020
In Q2, Amedisys, Inc. had in-house lobbyists. The report was filed on July 20, 2020.
Original Filing: 301195551.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to COVID-19 and related legislation (H.R. 6201, Families First Coronavirus Response Act & H.R. 748 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)) and related regulatory action including CMS-1744-IFC- Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency ; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design; H.R. 6800 (Health and Economic Recovery Omnibus Emergency Solutions Act); H.R. 266 (Paycheck Protection Program and Health Care Enhancement Act).
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2020
In Q1, Amedisys, Inc. had in-house lobbyists. The report was filed on April 10, 2020.
Original Filing: 301155238.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to COVID-19 and related legislation (H.R. 6201, Families First Coronavirus Response Act & H.R. 748 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)) and related regulatory action including CMS-1744-IFC- Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency ; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design;
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2019
In Q4, Amedisys, Inc. had in-house lobbyists. The report was filed on Jan. 13, 2020.
Original Filing: 301104851.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; H.R. 2573/S. 433 - Home Health Payment Innovation Act of 2019; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design Demonstration; S. 296/H.R. 2150 - Home Care Planning & Improvement Act; S. 2080/H.R. 647 - Enhance Palliative and Hospice Education and Training Act; S. 1190/H.R. 2594 - Rural Access to Hospice Act 2019; S. 1725/H.R. 3127 - Home Health Flexibility Act 2019; S. 2807 - Hospice Care Improvement Act of 2019.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2019
In Q3, Amedisys, Inc. had in-house lobbyists. The report was filed on Oct. 17, 2019.
Original Filing: 301067990.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; H.R. 2573/S. 433 - Home Health Payment Innovation Act of 2019; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design Demonstration; S. 296/H.R. 2150 - Home Care Planning & Improvement Act; S. 2080/H.R. 647 - Enhance Palliative and Hospice Education and Training Act; S. 1190/H.R. 2594 - Rural Access to Hospice Act 2019; S. 1725/H.R. 3127 - Home Health Flexibility Act 2019
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2019
In Q2, Amedisys, Inc. had in-house lobbyists. The report was filed on July 18, 2019.
Original Filing: 301048512.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; H.R. 2573/S. 433 - Home Health Payment Innovation Act of 2019; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design Demonstration; S. 296/H.R. 2150 - Home Care Planning & Improvement Act; S. 2080/H.R. 647 - Enhance Palliative and Hospice Education and Training Act; S. 1190/H.R. 2594 - Rural Access to Hospice Act 2019; S. 1725/H.R. 3127 - Home Health Flexibility Act 2019
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2019
In Q1, Amedisys, Inc. had in-house lobbyists. The report was filed on April 15, 2019.
Original Filing: 301025293.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; S. 433 - Home Health Payment Innovation Act of 2019; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design Demonstration.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2018
Amedisys, Inc. amended a lobbying report for in-house lobbying in Q42018 on March 25, 2019
Original Filing: 301021799.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; S. 3458 & HR 6932, amendments to the Social Security Act related to home health payment under Medicare; S. 3545 Home Health Payment Innovation Act.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2018
In Q4, Amedisys, Inc. had in-house lobbyists. The report was filed on Jan. 11, 2019.
Original Filing: 301003891.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; S. 3458 & HR 6932, amendments to the Social Security Act related to home health payment under Medicare; S. 3545 Home Health Payment Innovation Act.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2018
In Q3, Amedisys, Inc. had in-house lobbyists. The report was filed on Oct. 16, 2018.
Original Filing: 300985751.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; S. 3458 & HR 6932, amendments to the Social Security Act related to home health payment under Medicare.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2018
In Q2, Amedisys, Inc. had in-house lobbyists. The report was filed on July 13, 2018.
Original Filing: 300964761.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2018
In Q1, Amedisys, Inc. had in-house lobbyists. The report was filed on April 19, 2018.
Original Filing: 300951591.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; Home Health Care Planning Improvement Act H.R.1825, S.445; Preserve Access to Medicare Rural Home Health Services Act -S.353; Home Health Documentation and Program Improvement Act of 2017, H.R.2663; Bipartisan Budget Act of 2018; Consolidated Appropriations Act of 2018 (H.R. 1625).
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2017
In Q4, Amedisys, Inc. had in-house lobbyists. The report was filed on Jan. 16, 2018.
Original Filing: 300924697.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; Home Health Care Planning Improvement Act H.R.1825, S.445; Preserve Access to Medicare Rural Home Health Services Act -S.353; Home Health Documentation and Program Improvement Act of 2017, H.R.2663; Home Health Groupings Model/ Calendar Year 2018 Home Health Prospective Payment System (HHPPS) Rate Update Proposed Rule
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2017
In Q3, Amedisys, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2017.
Original Filing: 300914567.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; Home Health Care Planning Improvement Act H.R.1825, S.445; Preserve Access to Medicare Rural Home Health Services Act -S.353; Home Health Documentation and Program Improvement Act of 2017, H.R.2663; Home Health Groupings Model/ Calendar Year 2018 Home Health Prospective Payment System (HHPPS) Rate Update Proposed Rule
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2017
In Q2, Amedisys, Inc. had in-house lobbyists. The report was filed on July 18, 2017.
Original Filing: 300887900.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; Home Health Care Planning Improvement Act H.R.1825, S.445; Preserve Access to Medicare Rural Home Health Services Act -S.353; Home Health Documentation and Program Improvement Act of 2017, H.R.2663; Home Health Groupings Model/ Calendar Year 2018 Home Health Prospective Payment System (HHPPS) Rate Update Proposed Rule
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2017
In Q1, Amedisys, Inc. had in-house lobbyists. The report was filed on April 19, 2017.
Original Filing: 300869554.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2016
In Q4, Amedisys, Inc. had in-house lobbyists. The report was filed on Jan. 23, 2017.
Original Filing: 300857982.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; H.R.3298 - Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.6226 - PUSH Act of 2016 (Pre-Claims Undermine Seniors' Health Act)
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2016
In Q3, Amedisys, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2016.
Original Filing: 300839716.xml
Lobbying Issues
Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; H.R.3298 - Medicare Post-Acute Care Value-Based Purchasing Act of 2015; H.R.6226 - PUSH Act of 2016 (Pre-Claims Undermine Seniors' Health Act)
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2016
Amedisys, Inc. filed a lobbying registration on Aug. 2, 2016 for in-house lobbying efforts, effective July 1, 2016.
Original Filing: 300823147.xml
Issue(s) they said they’d lobby about: Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice. .
1st Quarter, 2014
Amedisys in-house lobbying effort was terminated on April 21, 2014
Original Filing: 300644369.xml
Lobbying Issues
Medicare post-acute care reform, chronic care reform, Home Health Prospective Payment System Rate Update for CY 2014 (CMS-1450-F), S.1932/H.R. 3890: Better Care, Lower Cost Act, H.R. 3796: Comprehensive Care Payment Innovation Act, S. 1871: SGR Repeal and Medicare Beneficiary Access Act of 2013, H.R. 4015: SGR Repeal and Medicare Provider Payment Modernization Act of 2014, S. 596: Fostering Independence Through Technology (FITT) Act
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Amedisys had in-house lobbyists. The report was filed on Jan. 21, 2014.
Original Filing: 300626250.xml
Lobbying Issues
home health and hospice reimbursement, hhpps, program integrity, post-acute care reform
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Amedisys had in-house lobbyists. The report was filed on Oct. 21, 2013.
Original Filing: 300604468.xml
Lobbying Issues
Home health and hospice payment regulations, Meficare program integrity, post-acute care reform
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Amedisys had in-house lobbyists. The report was filed on July 22, 2013.
Original Filing: 300584716.xml
Lobbying Issues
Home health and hospice payment regulations
post acute care reform
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Amedisys had in-house lobbyists. The report was filed on April 22, 2013.
Original Filing: 300560933.xml
Lobbying Issues
Medicare reimbursement, program integrity, delivery system reform
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
Amedisys filed a lobbying registration on Feb. 12, 2013 for in-house lobbying efforts, effective Jan. 1, 2013.
Original Filing: 300545465.xml
Issue(s) they said they’d lobby about: Medicare delivery system reform, Medicare reimbursement .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...